NCT02343718 2023-08-04
Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Canadian Cancer Trials Group
Phase 1 Completed
Canadian Cancer Trials Group
Case Comprehensive Cancer Center
The Hospital for Sick Children
University of Cologne
Seagen Inc.
Children's Oncology Group
National Institutes of Health Clinical Center (CC)